Viatris (VTRS) Jumps 10% on Reaffirmed Growth Targets

Core Insights - Viatris Inc. (NASDAQ: VTRS) has shown strong performance, with a 10.13% increase in stock price, closing at $11.20 after reaffirming growth targets at the UBS Healthcare Conference [1] - The company aims to return $1 billion to shareholders this year through dividends and share repurchases [1] - Year-to-date, Viatris has returned over $920 million to shareholders, including $500 million in share repurchases [2] Financial Performance - For full-year 2025, Viatris raised its revenue growth guidance to a range of $13.9 billion to $14.3 billion, up from the previous range of $13.5 billion to $14 billion [3] - Adjusted EBITDA guidance was also upgraded to a range of $4 billion to $4.2 billion, compared to the earlier range of $3.89 billion to $4.19 billion [3] - In Q3, Viatris reported a net loss of $128.2 million, a decline from a net income of $94.8 million in the same period last year, with revenues remaining flat at $3.7 billion [4]